Erenumab for Idiosyncratic Facial Pain

Summary

This is a phase IV randomized, double-blinded, placebo-controlled study to evaluate the efficacy of Erenumab in subjects with midfacial pain or pressure, without clinical or radiographic evidence of sinusitis.

Timeline

Start

2021-02-10

Primary completion

2023-07-11

Completion

2023-07-11

Drugs

Indications